Cerebrospinal fluid proteins in subclinical and overt hypothyroidism

Acta Neurologica Scandinavica
E NyströmC Wikkelsö

Abstract

We analysed cerebrospinal fluid (CSF) albumin and immunoglobulin G (IgG) concentrations and psychometric performance in subclinical (n = 6) and overt hypothyroidism (n = 9) before and after 6 months with L-thyroxine. In overt hypothyroidism, CSF albumin and IgG concentrations were increased before therapy [mean(SD): 328(156) mg/l and 69(27) mg/l], but within the reference interval [198(48) mg/l and 39(11) mg/l], P < 0.05, after therapy. In contrast, in subclinical hypothyroidism CSF protein concentrations were within the reference intervals before and after therapy. Psychometric testing indicated an improvement in performance in both groups. The increase in CSF proteins in overt hypothyroidism does not appear to be related to thyroid autoimmune disease per se, since we found no increase in CSF proteins in individuals with subclinical hypothyroidism and presence of thyroid antibodies. The increase might rather be caused by a blood-brain barrier dysfunction related to low thyroid hormone concentrations.

References

Jun 15, 1973·Annals of the New York Academy of Sciences·D Wellner, M B Hayes
Jul 1, 1980·Analytical Biochemistry·B R OakleyN R Morris
Jul 1, 1958·Neurology·S N NICKEL, B FRAME

❮ Previous
Next ❯

Citations

Mar 27, 2007·Thyroid : Official Journal of the American Thyroid Association·Mary H SamuelsJeri S Janowsky
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F DeisenhammerUNKNOWN EFNS Task Force
Sep 30, 2010·Veterinary Clinical Pathology·Theresa PancottoKurt L Zimmerman
Oct 25, 2012·American Journal of Physiology. Endocrinology and Metabolism·Julie A MonkSamantha J Richardson
Jan 1, 2000·Lancet·M RazaviR W Fincham
Jun 4, 2014·Endocrinology and Metabolism Clinics of North America·Mary H Samuels
Aug 15, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Mary H Samuels
May 3, 2007·The Journal of Clinical Endocrinology and Metabolism·M H SamuelsJ S Janowsky
Jun 14, 2019·Journal of Medical Case Reports·Matthias HepprichMatthias Johannes Betz
Mar 3, 2021·Journal of Neurology·Jakob RathFritz Zimprich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.